Effect of recombinant human IL-3 on the mitotic index and karyotype of hemopoietic cells.

[1]  A. de la Chapelle,et al.  Higher frequency of 51--clone in bone marrow mitoses after culture than by a direct method. , 2009, Scandinavian journal of haematology.

[2]  Y. Kaneko,et al.  G-CSF for chromosome analysis of myeloid leukemias and MDS. , 1990, Cancer genetics and cytogenetics.

[3]  E. Mitchell.  A cytogenetic study of male breast cancer. , 1990, Cancer genetics and cytogenetics.

[4]  R. Gale,et al.  Use of conditioned media in cell culture can mask cytogenetic abnormalities in acute leukemia. , 1990, Cancer genetics and cytogenetics.

[5]  G. Johnson,et al.  Proliferative properties of unfractionated, purified, and single cell human progenitor populations stimulated by recombinant human interleukin-3. , 1990, Blood.

[6]  A. de la Chapelle,et al.  Human bone marrow cytogenetics: growth factors stimulate metaphases for specific lineages. , 1989, Leukemia.

[7]  W. Piacibello,et al.  Interaction of transforming growth factor-beta 1 with hemopoietic growth factors in the regulation of human normal and leukemic myelopoiesis. , 1989, Experimental hematology.

[8]  F. Ruscetti,et al.  Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro. , 1988, Blood.

[9]  T. Yokota,et al.  Effects of recombinant human interleukin-3 on CD34-enriched normal hematopoietic progenitors and on myeloblastic leukemia cells. , 1988, Blood.

[10]  T. Hoang,et al.  Transforming growth factor beta inhibits the proliferation of the blast cells of acute myeloblastic leukemia. , 1988 .

[11]  M. Minden,et al.  The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension culture. , 1988, Leukemia.

[12]  Y. Sonoda,et al.  Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  L. Dorssers,et al.  Stimulating spectrum of human recombinant multi-CSF (IL-3) on human marrow precursors: importance of accessory cells. , 1988, Blood.

[14]  G. Wagemaker,et al.  Human recombinant multilineage colony stimulating factor (interleukin-3): stimulator of acute myelocytic leukemia progenitor cells in vitro. , 1987, Blood.

[15]  J. Michaeli,et al.  Stimulation of proliferation of human myeloid leukemia cells in culture: applications for cytogenetic analysis. , 1986, Blood.

[16]  I. Jinnai,et al.  A culture technique for chromosome analysis in human myeloid leukemias. , 1986, Cancer genetics and cytogenetics.

[17]  J. Rowley,et al.  The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: a 12-year study (1970-1982). , 1983, Cancer genetics and cytogenetics.

[18]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.

[19]  J. Rowley,et al.  Methods of processing marrow samples may affect the frequency of detectable aneuploid cells , 1981, American journal of hematology.

[20]  A. de la Chapelle,et al.  Culture of bone marrow reveals more cells with chromosomal abnormalities than the direct method in patients with hematologic disorders. , 1981, Blood.

[21]  F. Mandelli,et al.  Effect of Hemopoietic Growth Factors on the Proliferation of Acute Myeloid and Lymphoid Leukemias. , 1990, Leukemia & lymphoma.

[22]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .

[23]  E. Hook.  Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use. , 1977, American journal of human genetics.